Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1573-7217
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer ; day:11 ; month:5 ; year:2022 ; pages:1-13
Breast cancer research and treatment ; (11.5.2022), 1-13

Urheber
O’Shaughnessy, Joyce
Brufsky, Adam
Rugo, Hope S.
Tolaney, Sara M.
Punie, Kevin
Sardesai, Sagar
Hamilton, Erika
Loirat, Delphine
Traina, Tiffany
Leon-Ferre, Roberto
Hurvitz, Sara A.
Kalinsky, Kevin
Bardia, Aditya
Henry, Stephanie
Mayer, Ingrid
Zhu, Yanni
Phan, See
Cortés, Javier
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s10549-022-06602-7
URN
urn:nbn:de:101:1-2022071709354657657232
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:26 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • O’Shaughnessy, Joyce
  • Brufsky, Adam
  • Rugo, Hope S.
  • Tolaney, Sara M.
  • Punie, Kevin
  • Sardesai, Sagar
  • Hamilton, Erika
  • Loirat, Delphine
  • Traina, Tiffany
  • Leon-Ferre, Roberto
  • Hurvitz, Sara A.
  • Kalinsky, Kevin
  • Bardia, Aditya
  • Henry, Stephanie
  • Mayer, Ingrid
  • Zhu, Yanni
  • Phan, See
  • Cortés, Javier
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Metastatic Triple-Negative Breast Cancer

Metastatic Triple-Negative Breast Cancer

Characterizing triple-negative breast cancer tumors

Characterizing triple-negative breast cancer tumors

Triple-Negative Breast Cancer: Multimodality Appearance

Triple-Negative Breast Cancer: Multimodality Appearance

MicroRNA signatures in triple-negative breast cancer

Hochschulschrift

MicroRNA signatures in triple-negative breast cancer

Immune-related biomarkers in triple-negative breast cancer

Immune-related biomarkers in triple-negative breast cancer

New Vaccine Therapy for Triple-Negative Breast Cancer

New Vaccine Therapy for Triple-Negative Breast Cancer

Advances in immunotherapy for triple-negative breast cancer

Advances in immunotherapy for triple-negative breast cancer

The Triple-Negative Breast Cancer Database: an omics platform for reference, integration and analysis of triple-negative breast cancer data

The Triple-Negative Breast Cancer Database: an omics platform for reference, integration and analysis of triple-negative breast cancer data

Triple-negative breast cancer molecular subtyping and treatment progress

Triple-negative breast cancer molecular subtyping and treatment progress

Repurposing mebendazole against triple-negative breast cancer CNS metastasis

Repurposing mebendazole against triple-negative breast cancer CNS metastasis

Role of ICAM-1 in triple-negative breast cancer

Role of ICAM-1 in triple-negative breast cancer

Immunotherapy in Triple-Negative Breast Cancer: Present and Future

Immunotherapy in Triple-Negative Breast Cancer: Present and Future

Verbundene Objekte